{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:25:18Z","timestamp":1794007518343,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.gastro.2026.06.022","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:05:36Z","timestamp":1783929936000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Incidence of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance"],"prefix":"10.1053","author":[{"given":"Soleiman","family":"El-Debeiky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Hiu-Fung","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy Sze-Man","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Kit","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki Wing-Ki","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy Che-To","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Lik-Yuen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Lai-Hung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry Cheuk-Fung","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2026.06.022_bib1","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2023.06.002","article-title":"Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference","volume":"79","author":"Ghany","year":"2023","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cgh.2019.08.033","article-title":"How do we determine whether a functional cure for HBV infection has been achieved?","volume":"18","author":"Yip","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jhep.2018.10.014","article-title":"HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues","volume":"70","author":"Yip","year":"2019","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cgh.2020.05.041","article-title":"Association between seroclearance of hepatitis B surface antigen and long-term clinical outcomes of patients with chronic hepatitis B virus infection: systematic review and meta-analysis","volume":"19","author":"Anderson","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib5","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jhep.2017.06.019","article-title":"Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance","volume":"67","author":"Yip","year":"2017","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/apt.16174","article-title":"Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue-induced hepatitis B surface antigen loss","volume":"53","author":"Yip","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.06.022_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cgh.2017.12.009","article-title":"Effects of diabetes and glycemic control on risk of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen","volume":"16","author":"Yip","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2022.03.032","article-title":"A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance","volume":"77","author":"Yang","year":"2022","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/apt.17933","article-title":"CAMP-B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance","volume":"59","author":"Lee","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.06.022_bib10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jhep.2014.11.031","article-title":"Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance","volume":"62","author":"Kim","year":"2015","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2022.11.020","article-title":"Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss","volume":"78","author":"Yip","year":"2023","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib12","first-page":"S75","article-title":"Hepatitis B surface antigen seroclearance in a cohort of 154,740 patients with chronic hepatitis B: a 15-year follow-up study","volume":"11","author":"Yip","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2026.06.022_bib13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.gastro.2018.10.027","article-title":"Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis","volume":"156","author":"Yeo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.06.022_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/jvh.13471","article-title":"Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: a meta-analysis","volume":"28","author":"Song","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1053\/j.gastro.2026.06.022_bib15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/HEP.0000000000001549","article-title":"AASLD ISDA practice guideline on treatment of chronic hepatitis B","volume":"83","author":"Ghany","year":"2026","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2026.06.022_bib16","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development?","volume":"76","author":"Wong","year":"2022","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.37349\/edd.2024.00046","article-title":"Hepatocellular carcinoma surveillance after HBsAg seroclearance","volume":"3","author":"Lai","year":"2024","journal-title":"Explor Digest Dis"},{"key":"10.1053\/j.gastro.2026.06.022_bib18","series-title":"MEDINFO 2010 : Proceedings of the 13th World Congress on Medical Informatics","first-page":"1468","article-title":"Development journey of Clinical Data Analysis and Reporting System (CDARS) in Hospital Authority of Hong Kong","author":"Cheng","year":"2010"},{"key":"10.1053\/j.gastro.2026.06.022_bib21","unstructured":"Census and Statistics Department. Government of the Hong Kong Special Administrative Region. Table 110-01001: Population by Sex and Age Group. Available at: https:\/\/www.censtatd.gov.hk\/en\/web_table.html?id=110-01001. Accessed 14 April 2026."},{"key":"10.1053\/j.gastro.2026.06.022_bib22","author":"Cho"},{"key":"10.1053\/j.gastro.2026.06.022_bib23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib24","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jhep.2018.07.018","article-title":"Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy","volume":"69","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib25","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.gastro.2026.06.022_bib26","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2026.06.022_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2026.06.022_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-0039-1678728","article-title":"Current Knowledge of occult hepatitis B infection and clinical implications","volume":"39","author":"Yip","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2026.06.022_bib30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2019.12.005","article-title":"Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B","volume":"72","author":"Yip","year":"2020","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib31","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.06.022_bib32","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/hep.31612","article-title":"Association of metabolic risk factors with risks of cancer and all-cause mortality in patients with chronic hepatitis B","volume":"73","author":"Lee","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2026.06.022_bib33","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.3390\/cancers14236012","article-title":"Metabolic-associated fatty liver disease, hepatitis B surface antigen seroclearance, and long-term risk of hepatocellular carcinoma in chronic hepatitis B","volume":"14","author":"Yu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.gastro.2026.06.022_bib34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/jvh.13452","article-title":"Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis","volume":"28","author":"Campbell","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1053\/j.gastro.2026.06.022_bib35","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/hep.32803","article-title":"Does hepatic steatosis impact chronic hepatitis B?","volume":"77","author":"Yip","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2026.06.022_bib36","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/apt.14341","article-title":"Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis","volume":"46","author":"Wong","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.06.022_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bpobgyn.2020.03.014","article-title":"Hepatitis B-management of acute infection and active inflammation in pregnancy-a hepatologist's perspective","volume":"68","author":"Wong","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1053\/j.gastro.2026.06.022_bib38","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/gast.2002.33588","article-title":"Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C","volume":"122","author":"Chu","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.06.022_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/apt.12207","article-title":"Meta-analysis: The association of hepatitis B virus genotypes and hepatocellular carcinoma","volume":"37","author":"Wong","year":"2013","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526070435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526070435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:32:24Z","timestamp":1794004344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508526070435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S0016508526070435"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2026.06.022","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Incidence of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2026.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}